Title |
A Biomarker to Differentiate between Primary and Cocaine-Induced Major Depression in Cocaine Use Disorder: The Role of Platelet IRAS/Nischarin (I1-Imidazoline Receptor)
|
---|---|
Published in |
Frontiers in Psychiatry, December 2017
|
DOI | 10.3389/fpsyt.2017.00258 |
Pubmed ID | |
Authors |
Benjamin Keller, Joan-Ignasi Mestre-Pinto, María Álvaro-Bartolomé, Diana Martinez-Sanvisens, Magí Farre, M. Julia García-Fuster, Jesús A. García-Sevilla, Marta Torrens |
Abstract |
The association of cocaine use disorder (CUD) and comorbid major depressive disorder (MDD; CUD/MDD) is characterized by high prevalence and poor treatment outcomes. CUD/MDD may be primary (primary MDD) or cocaine-induced (CUD-induced MDD). Specific biomarkers are needed to improve diagnoses and therapeutic approaches in this dual pathology. Platelet biomarkers [5-HT2A receptor and imidazoline receptor antisera selected (IRAS)/nischarin] were assessed by Western blot in subjects with CUD and primary MDD (n = 16) or CUD-induced MDD (n = 9; antidepressant free, AD-; antidepressant treated, AD+) and controls (n = 10) at basal level and/or after acute tryptophan depletion (ATD). Basal platelet 5-HT2A receptor (monomer) was reduced in comorbid CUD/MDD subjects (all patients: 43%) compared to healthy controls, and this down-regulation was independent of AD medication (decreases in AD-: 47%, and in AD+: 40%). No basal differences were found for IRAS/nischarin contents in AD+ and AD- comorbid CUD/MDD subjects. The comparison of IRAS/nischarin in the different subject groups during/after ATD showed opposite modulations (i.e., increases and decreases) in response to low plasma tryptophan levels with significant differences discriminating between the subgroups of CUD with primary MDD and CUD-induced MDD. These specific alterations suggested that platelet IRAS/nischarin might be useful as a biomarker to discriminate between primary and CUD-induced MDD in this dual pathology. |
Twitter Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 4 | 67% |
Switzerland | 1 | 17% |
Unknown | 1 | 17% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 83% |
Science communicators (journalists, bloggers, editors) | 1 | 17% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 28 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 5 | 18% |
Student > Bachelor | 4 | 14% |
Other | 3 | 11% |
Student > Master | 2 | 7% |
Student > Ph. D. Student | 2 | 7% |
Other | 3 | 11% |
Unknown | 9 | 32% |
Readers by discipline | Count | As % |
---|---|---|
Neuroscience | 5 | 18% |
Psychology | 4 | 14% |
Medicine and Dentistry | 4 | 14% |
Nursing and Health Professions | 1 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 4% |
Other | 1 | 4% |
Unknown | 12 | 43% |